Jane L Mendillo insider trades: Generate Biomedicines (GENB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jane reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | GENB | ↑ Buy | 1,500 | $16.00 | $24K | Direct | Mar 2, 2026 (0d) |
| Aug 18, 2017 | GM | ↑ Buy | 1,440 | $34.86 | $50K | Direct | Aug 22, 2017 (4d) |
| May 26, 2017 | GM | ↑ Buy | 1,520 | $32.92 | $50K | Direct | May 26, 2017 (0d) |
| Aug 2, 2016 | GM | ↑ Buy | 1,600 | $31.01 | $50K | Direct | Aug 4, 2016 (2d) |
| Aug 2, 2016 | LAZ | ↑ Buy | 1,400 | $35.22 | $49K | Direct | Aug 4, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GENB insiders
Open-market trades in the last 12 months
About Jane L Mendillo's insider trades
Jane L Mendillo is an insider at Generate Biomedicines (GENB). Since Aug 2, 2016, Jane has reported 5 open-market purchases worth $223K and no sales on SEC Form 4. In the last 12 months: 1 buy ($24K).
Their filings also include grants and awards (54 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GENB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.